MEERA GOPAL IYENGAR MD NPI 1548429681

NPI Information

  • NPI: 1548429681
  • Provider Name: MEERA GOPAL IYENGAR, MD
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1340 N HANCOCK ROAD
    CLERMONT, FL
    ZIP 34711
  • Phone: (352) 394-1150

Map and Directions

Get Directions

NPI Details

Meera Gopal Iyengar, MD is a medical oncology internal medicine in Clermont, FL with 18 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Meera Gopal Iyengar, MD NPI is 1548429681. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE
Graduation Year:2008

The provider's business location address is:

1340 N HANCOCK ROAD
CLERMONT, FL
ZIP 34711-931
Phone: (352) 394-1150
Fax: (352) 394-1560

The NPI 1548429681 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, omalizumab, 5 mg (HCPCS:J2357)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, iron dextran, 50 mg (HCPCS:J1750)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Protein measurement, serum (HCPCS:84165)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Blood test, clotting time (HCPCS:85610)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Folic acid level, serum (HCPCS:82746)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Magnesium level (HCPCS:83735)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Automated urinalysis test (HCPCS:81003)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
  • Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
  • Vitamin d-3 level (HCPCS:82306)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Haptoglobin (serum protein) level (HCPCS:83010)

The enumeration date for this NPI number is 6/4/2008 and was last updated on 2/13/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical OncologyME119000FLORIDAYes
2207RH0000XInternal MedicineHematologyME119000FLORIDANo

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1010924300MEDICAIDFLORIDA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.